Melis Nuray Anahtar, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Lactobacillus | 3 | 2018 | 189 | 1.090 |
Why?
|
Vagina | 3 | 2018 | 825 | 0.880 |
Why?
|
Pneumocystis carinii | 1 | 2021 | 74 | 0.780 |
Why?
|
Enterococcus faecium | 1 | 2021 | 99 | 0.760 |
Why?
|
Tuberculosis, Meningeal | 1 | 2021 | 45 | 0.750 |
Why?
|
Listeriosis | 1 | 2021 | 149 | 0.730 |
Why?
|
Pneumonia, Pneumocystis | 1 | 2021 | 249 | 0.720 |
Why?
|
Laboratories, Hospital | 1 | 2021 | 194 | 0.700 |
Why?
|
Listeria monocytogenes | 1 | 2021 | 250 | 0.690 |
Why?
|
Brain Abscess | 1 | 2020 | 119 | 0.680 |
Why?
|
Mucormycosis | 1 | 2020 | 97 | 0.670 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2021 | 340 | 0.660 |
Why?
|
Cerebrospinal Fluid | 1 | 2021 | 533 | 0.610 |
Why?
|
Graves Disease | 1 | 2019 | 242 | 0.610 |
Why?
|
Tachycardia, Supraventricular | 1 | 2019 | 263 | 0.580 |
Why?
|
Vaginosis, Bacterial | 1 | 2018 | 128 | 0.570 |
Why?
|
Facial Paralysis | 1 | 2020 | 338 | 0.540 |
Why?
|
Cerebral Infarction | 1 | 2021 | 1011 | 0.530 |
Why?
|
Obstetric Labor Complications | 1 | 2018 | 238 | 0.530 |
Why?
|
RNA, Ribosomal, 16S | 2 | 2016 | 954 | 0.520 |
Why?
|
Substance Abuse, Intravenous | 1 | 2020 | 525 | 0.510 |
Why?
|
Renal Insufficiency | 1 | 2020 | 805 | 0.470 |
Why?
|
Anti-Infective Agents | 1 | 2021 | 971 | 0.460 |
Why?
|
Amyloidosis | 1 | 2020 | 795 | 0.450 |
Why?
|
Metagenomics | 1 | 2016 | 428 | 0.430 |
Why?
|
Lung | 2 | 2021 | 9858 | 0.430 |
Why?
|
Abdominal Pain | 3 | 2021 | 1064 | 0.360 |
Why?
|
Mycobacterium tuberculosis | 1 | 2021 | 1832 | 0.360 |
Why?
|
Pregnancy Complications, Infectious | 1 | 2021 | 2027 | 0.350 |
Why?
|
Anti-Bacterial Agents | 3 | 2023 | 7172 | 0.340 |
Why?
|
Diagnosis, Differential | 5 | 2021 | 12954 | 0.320 |
Why?
|
Host-Pathogen Interactions | 1 | 2015 | 1479 | 0.280 |
Why?
|
Kidney | 1 | 2020 | 7185 | 0.240 |
Why?
|
Drug Resistance, Bacterial | 2 | 2021 | 1030 | 0.230 |
Why?
|
Phylogeny | 2 | 2021 | 2796 | 0.230 |
Why?
|
High-Throughput Nucleotide Sequencing | 1 | 2016 | 3591 | 0.230 |
Why?
|
Brain | 2 | 2021 | 26345 | 0.230 |
Why?
|
Headache | 2 | 2021 | 1224 | 0.220 |
Why?
|
Elafin | 1 | 2022 | 33 | 0.220 |
Why?
|
beta-Defensins | 1 | 2022 | 57 | 0.220 |
Why?
|
Abortion, Missed | 1 | 2021 | 11 | 0.200 |
Why?
|
Hepatomegaly | 1 | 2021 | 85 | 0.200 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2021 | 43 | 0.200 |
Why?
|
Emergency Service, Hospital | 1 | 2021 | 7658 | 0.200 |
Why?
|
Splenomegaly | 1 | 2021 | 190 | 0.200 |
Why?
|
Lethargy | 1 | 2021 | 39 | 0.190 |
Why?
|
Ultrasonography, Doppler, Color | 1 | 2021 | 233 | 0.180 |
Why?
|
Dysarthria | 1 | 2020 | 57 | 0.180 |
Why?
|
Anaplasma phagocytophilum | 1 | 2020 | 37 | 0.180 |
Why?
|
Anaplasmosis | 1 | 2020 | 36 | 0.180 |
Why?
|
Patient Isolation | 1 | 2020 | 100 | 0.180 |
Why?
|
Acinetobacter Infections | 1 | 2020 | 69 | 0.170 |
Why?
|
Fetal Death | 1 | 2021 | 448 | 0.170 |
Why?
|
Microbial Sensitivity Tests | 2 | 2023 | 1870 | 0.170 |
Why?
|
Chemoprevention | 1 | 2021 | 319 | 0.170 |
Why?
|
Heroin Dependence | 1 | 2020 | 175 | 0.170 |
Why?
|
Peritoneal Dialysis | 1 | 2020 | 147 | 0.170 |
Why?
|
Acinetobacter baumannii | 1 | 2020 | 107 | 0.170 |
Why?
|
Nausea | 1 | 2021 | 674 | 0.160 |
Why?
|
Glomerulonephritis | 1 | 2020 | 372 | 0.150 |
Why?
|
Tomography, X-Ray Computed | 4 | 2021 | 20121 | 0.150 |
Why?
|
Genome, Viral | 1 | 2020 | 665 | 0.140 |
Why?
|
CD8-Positive T-Lymphocytes | 3 | 2019 | 4477 | 0.140 |
Why?
|
Vomiting | 1 | 2019 | 636 | 0.140 |
Why?
|
South Africa | 3 | 2017 | 1731 | 0.140 |
Why?
|
Hepatitis B Surface Antigens | 1 | 2017 | 304 | 0.140 |
Why?
|
Radiography, Abdominal | 1 | 2019 | 537 | 0.140 |
Why?
|
Hepatitis B Vaccines | 1 | 2017 | 194 | 0.140 |
Why?
|
Drug Discovery | 1 | 2023 | 1058 | 0.130 |
Why?
|
Abdomen | 1 | 2021 | 1117 | 0.130 |
Why?
|
Epitopes, T-Lymphocyte | 1 | 2019 | 880 | 0.130 |
Why?
|
Methotrexate | 1 | 2021 | 1726 | 0.130 |
Why?
|
Kidney Calculi | 1 | 2019 | 465 | 0.130 |
Why?
|
Bacteria | 2 | 2016 | 2112 | 0.120 |
Why?
|
Sequence Analysis | 1 | 2015 | 256 | 0.120 |
Why?
|
Humans | 28 | 2023 | 743811 | 0.120 |
Why?
|
Radiography, Thoracic | 1 | 2021 | 1265 | 0.120 |
Why?
|
Probiotics | 1 | 2018 | 350 | 0.120 |
Why?
|
Contraceptive Agents, Female | 1 | 2015 | 135 | 0.120 |
Why?
|
Progestins | 1 | 2015 | 306 | 0.120 |
Why?
|
Fever | 1 | 2021 | 1616 | 0.120 |
Why?
|
Hepatitis B virus | 1 | 2017 | 513 | 0.120 |
Why?
|
Africa | 1 | 2015 | 672 | 0.110 |
Why?
|
RNA, Viral | 1 | 2021 | 2901 | 0.110 |
Why?
|
Dyspnea | 1 | 2021 | 1303 | 0.110 |
Why?
|
Cervix Uteri | 1 | 2017 | 590 | 0.110 |
Why?
|
Antibodies, Viral | 2 | 2020 | 3175 | 0.110 |
Why?
|
Immunization | 1 | 2017 | 1255 | 0.110 |
Why?
|
AIDS Vaccines | 1 | 2019 | 938 | 0.110 |
Why?
|
Biodiversity | 1 | 2015 | 341 | 0.110 |
Why?
|
Glucocorticoids | 1 | 2021 | 2107 | 0.100 |
Why?
|
Placenta | 1 | 2021 | 1699 | 0.100 |
Why?
|
Hepatitis B | 1 | 2017 | 693 | 0.100 |
Why?
|
Stomach Neoplasms | 1 | 2021 | 1332 | 0.100 |
Why?
|
HIV-1 | 3 | 2019 | 6939 | 0.100 |
Why?
|
Cross Infection | 1 | 2020 | 1416 | 0.090 |
Why?
|
Radiography | 1 | 2021 | 7010 | 0.090 |
Why?
|
Acquired Immunodeficiency Syndrome | 1 | 2019 | 2232 | 0.090 |
Why?
|
Feces | 1 | 2016 | 1397 | 0.090 |
Why?
|
Female | 12 | 2022 | 380020 | 0.090 |
Why?
|
Silicon | 1 | 2009 | 145 | 0.080 |
Why?
|
Artificial Intelligence | 1 | 2021 | 2210 | 0.080 |
Why?
|
Pregnancy | 2 | 2021 | 29140 | 0.080 |
Why?
|
HIV Infections | 4 | 2017 | 16715 | 0.080 |
Why?
|
Lectins, C-Type | 1 | 2011 | 589 | 0.080 |
Why?
|
Titanium | 1 | 2009 | 487 | 0.070 |
Why?
|
Ultrasonography | 1 | 2020 | 5986 | 0.070 |
Why?
|
Magnetic Resonance Imaging | 3 | 2021 | 35409 | 0.070 |
Why?
|
Cadherins | 1 | 2011 | 907 | 0.070 |
Why?
|
Electrocardiography | 1 | 2019 | 6441 | 0.070 |
Why?
|
Drug Delivery Systems | 1 | 2017 | 2217 | 0.070 |
Why?
|
Predictive Value of Tests | 1 | 2021 | 15067 | 0.060 |
Why?
|
Cytokines | 2 | 2021 | 7324 | 0.060 |
Why?
|
Adult | 4 | 2021 | 213889 | 0.060 |
Why?
|
Sequence Analysis, DNA | 1 | 2016 | 4803 | 0.060 |
Why?
|
Nanostructures | 1 | 2009 | 552 | 0.060 |
Why?
|
Liver | 1 | 2019 | 7479 | 0.060 |
Why?
|
Boston | 3 | 2020 | 9310 | 0.060 |
Why?
|
Adenocarcinoma | 1 | 2021 | 6363 | 0.060 |
Why?
|
Interleukin-16 | 1 | 2022 | 33 | 0.060 |
Why?
|
Substance-Related Disorders | 1 | 2019 | 4254 | 0.050 |
Why?
|
Reproducibility of Results | 1 | 2021 | 19894 | 0.050 |
Why?
|
Hemolysis | 1 | 2004 | 420 | 0.050 |
Why?
|
Muramidase | 1 | 2022 | 174 | 0.050 |
Why?
|
Interleukin-1alpha | 1 | 2022 | 85 | 0.050 |
Why?
|
Lactoferrin | 1 | 2022 | 97 | 0.050 |
Why?
|
Inflammation | 1 | 2021 | 10629 | 0.050 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2022 | 297 | 0.050 |
Why?
|
Trans-Activators | 1 | 2011 | 2927 | 0.050 |
Why?
|
Mental Disorders | 1 | 2021 | 6593 | 0.050 |
Why?
|
Disease Outbreaks | 2 | 2020 | 1771 | 0.050 |
Why?
|
Granulocyte Colony-Stimulating Factor | 1 | 2022 | 648 | 0.040 |
Why?
|
Burn Units | 1 | 2020 | 136 | 0.040 |
Why?
|
Immunoglobulins | 1 | 2022 | 881 | 0.040 |
Why?
|
Microfluidics | 1 | 2004 | 662 | 0.040 |
Why?
|
Blood Cell Count | 1 | 2020 | 403 | 0.040 |
Why?
|
Menstrual Cycle | 1 | 2022 | 551 | 0.040 |
Why?
|
Carbapenems | 1 | 2020 | 117 | 0.040 |
Why?
|
Interferons | 1 | 2022 | 706 | 0.040 |
Why?
|
Image Enhancement | 1 | 2009 | 2915 | 0.040 |
Why?
|
gag Gene Products, Human Immunodeficiency Virus | 1 | 2019 | 222 | 0.040 |
Why?
|
Nucleic Acid Amplification Techniques | 1 | 2020 | 323 | 0.040 |
Why?
|
Progesterone | 1 | 2022 | 773 | 0.040 |
Why?
|
Diagnostic Techniques and Procedures | 1 | 2020 | 214 | 0.040 |
Why?
|
Interleukins | 1 | 2022 | 791 | 0.040 |
Why?
|
Injections, Jet | 1 | 2017 | 8 | 0.040 |
Why?
|
HLA-B Antigens | 1 | 2019 | 354 | 0.040 |
Why?
|
Virus Replication | 2 | 2019 | 2535 | 0.040 |
Why?
|
Injections, Intradermal | 1 | 2017 | 117 | 0.040 |
Why?
|
Chemokines | 1 | 2021 | 968 | 0.040 |
Why?
|
Methicillin-Resistant Staphylococcus aureus | 1 | 2023 | 687 | 0.040 |
Why?
|
Prevotella | 1 | 2017 | 79 | 0.040 |
Why?
|
Bacteria, Anaerobic | 1 | 2017 | 68 | 0.040 |
Why?
|
Contrast Media | 1 | 2009 | 5301 | 0.030 |
Why?
|
Community-Acquired Infections | 1 | 2020 | 465 | 0.030 |
Why?
|
Injections, Subcutaneous | 1 | 2017 | 667 | 0.030 |
Why?
|
Conserved Sequence | 1 | 2019 | 1202 | 0.030 |
Why?
|
Drug Resistance, Multiple, Bacterial | 1 | 2020 | 564 | 0.030 |
Why?
|
Staphylococcus aureus | 1 | 2023 | 1453 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14714 | 0.030 |
Why?
|
Clinical Laboratory Techniques | 1 | 2020 | 738 | 0.030 |
Why?
|
Blood-Brain Barrier | 1 | 2021 | 1018 | 0.030 |
Why?
|
Erythrocytes | 1 | 2004 | 2455 | 0.030 |
Why?
|
Staphylococcal Infections | 1 | 2023 | 1400 | 0.030 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2012 | 3874 | 0.030 |
Why?
|
Needles | 1 | 2017 | 449 | 0.030 |
Why?
|
Communicable Disease Control | 1 | 2020 | 856 | 0.030 |
Why?
|
Flow Cytometry | 2 | 2017 | 5973 | 0.030 |
Why?
|
Immunologic Factors | 1 | 2022 | 1580 | 0.030 |
Why?
|
RNA | 1 | 2023 | 2748 | 0.030 |
Why?
|
Injections | 1 | 2015 | 839 | 0.030 |
Why?
|
Histocompatibility Antigens Class I | 1 | 2019 | 1366 | 0.030 |
Why?
|
Interleukin-6 | 1 | 2022 | 3208 | 0.030 |
Why?
|
Retrospective Studies | 4 | 2023 | 77410 | 0.030 |
Why?
|
Micromanipulation | 1 | 2012 | 53 | 0.030 |
Why?
|
Contraception | 1 | 2015 | 359 | 0.030 |
Why?
|
Young Adult | 2 | 2015 | 56392 | 0.030 |
Why?
|
Algorithms | 2 | 2023 | 13869 | 0.030 |
Why?
|
Middle Aged | 2 | 2021 | 213241 | 0.020 |
Why?
|
Adolescent | 2 | 2015 | 85729 | 0.020 |
Why?
|
Skin | 1 | 2023 | 4372 | 0.020 |
Why?
|
Academic Medical Centers | 1 | 2020 | 2760 | 0.020 |
Why?
|
Proteome | 1 | 2019 | 1794 | 0.020 |
Why?
|
Crystallization | 1 | 2009 | 525 | 0.020 |
Why?
|
Animals | 5 | 2023 | 168660 | 0.020 |
Why?
|
Molecular Conformation | 1 | 2009 | 561 | 0.020 |
Why?
|
Aged | 1 | 2021 | 163178 | 0.020 |
Why?
|
Mice | 3 | 2023 | 81154 | 0.020 |
Why?
|
Mice, Inbred BALB C | 1 | 2017 | 6380 | 0.020 |
Why?
|
Alleles | 1 | 2019 | 6934 | 0.020 |
Why?
|
Lab-On-A-Chip Devices | 1 | 2012 | 428 | 0.020 |
Why?
|
Macromolecular Substances | 1 | 2009 | 1454 | 0.020 |
Why?
|
Male | 3 | 2020 | 349776 | 0.020 |
Why?
|
Nanomedicine | 1 | 2009 | 302 | 0.020 |
Why?
|
Surface Properties | 1 | 2009 | 1168 | 0.020 |
Why?
|
Hospitals | 1 | 2020 | 3953 | 0.020 |
Why?
|
Fluorescent Antibody Technique | 1 | 2011 | 2503 | 0.020 |
Why?
|
Intensive Care Units | 1 | 2020 | 3679 | 0.020 |
Why?
|
HLA Antigens | 1 | 2012 | 1382 | 0.020 |
Why?
|
Materials Testing | 1 | 2009 | 866 | 0.020 |
Why?
|
Nanotechnology | 1 | 2012 | 708 | 0.020 |
Why?
|
Cloning, Molecular | 1 | 2012 | 4320 | 0.020 |
Why?
|
Particle Size | 1 | 2009 | 1639 | 0.020 |
Why?
|
Epitopes | 1 | 2012 | 2570 | 0.020 |
Why?
|
Cell Separation | 1 | 2011 | 1750 | 0.020 |
Why?
|
Disease Models, Animal | 1 | 2023 | 18027 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 2011 | 1602 | 0.020 |
Why?
|
Receptors, Immunologic | 1 | 2011 | 1423 | 0.020 |
Why?
|
HIV | 1 | 2012 | 1604 | 0.020 |
Why?
|
CD4-Positive T-Lymphocytes | 1 | 2017 | 4386 | 0.010 |
Why?
|
Case-Control Studies | 1 | 2021 | 21733 | 0.010 |
Why?
|
Cohort Studies | 2 | 2017 | 40545 | 0.010 |
Why?
|
Prospective Studies | 2 | 2020 | 53250 | 0.010 |
Why?
|
Risk | 1 | 2015 | 9677 | 0.010 |
Why?
|
Interferon-gamma | 1 | 2012 | 3205 | 0.010 |
Why?
|
Rats, Inbred Lew | 1 | 2004 | 1162 | 0.010 |
Why?
|
Colon | 1 | 2011 | 1772 | 0.010 |
Why?
|
Diffusion | 1 | 2004 | 831 | 0.010 |
Why?
|
Proportional Hazards Models | 1 | 2015 | 12354 | 0.010 |
Why?
|
Hospitalization | 1 | 2020 | 10259 | 0.010 |
Why?
|
Lymphocyte Activation | 1 | 2011 | 5524 | 0.010 |
Why?
|
Incidence | 1 | 2015 | 20948 | 0.010 |
Why?
|
Genotype | 1 | 2012 | 12944 | 0.010 |
Why?
|
Immunohistochemistry | 1 | 2011 | 11360 | 0.010 |
Why?
|
Mutation | 1 | 2019 | 29777 | 0.010 |
Why?
|
T-Lymphocytes | 1 | 2012 | 10179 | 0.010 |
Why?
|
Rats | 1 | 2004 | 24250 | 0.000 |
Why?
|